CoChat
Cited by 228

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis

Open access
Alivernini, Stefano, Gremese, Elisa, McSharry, Charles, Tolusso, Barbara, Ferraccioli, Gianfranco, McInnes, Iain B., Kurowska-Stolarska, Mariola · 2018 · Frontiers in Immunology

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that fine-tune the cell response to a changing environment by modulating the cell transcriptome. miR-155 is a multifunctional miRNA enriched in cells of the immune system and is indispensable for the immune response. However, when deregulated, miR-155 contributes to the development of chronic inflammation, autoimmunity, cancer, and fibrosis. Herein, we review the evidence for the pathogenic role of miR-155 in driving aberrant activation of the immune system in rheumatoid arthritis, and its potential as a disease biomarker and therapeutic target.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2017.01932

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 143

  1. Baltimore, 2008, MicroRNAs: new regulators of immune cell development and function, Nat Immunol, 9, 839, 10.1038/ni.f.209 · DOI · Paper page
  2. He, 2004, MicroRNAs: small RNAs with a big role in gene regulation, Nat Rev Genet, 5, 522, 10.1038/nrg1415 · DOI
  3. Bartel, 2004, MicroRNAs, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  4. Watts, 2017, MicroRNA29a treatment improves early tendon injury, Mol Ther, 25, 2415, 10.1016/j.ymthe.2017.07.015 · DOI
  5. Nagy, 2015, Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?, Arthritis Res Ther, 17, 181, 10.1186/s13075-015-0707-1 · DOI
  6. Ospelt, 2017, Epigenetics in the pathogenesis of RA, Semin Immunopathol, 39, 409, 10.1007/s00281-017-0621-5 · DOI
  7. Kim, 2009, Biogenesis of small RNAs in animals, Nat Rev Mol Cell Biol, 10, 126, 10.1038/nrm2632 · DOI · Paper page
  8. Brennecke, 2005, Principles of microRNA-target recognition, PLoS Biol, 3, e85, 10.1371/journal.pbio.0030085 · DOI · Paper page
  9. Doench, 2004, Specificity of microRNA target selection in translational repression, Genes Dev, 18, 504, 10.1101/gad.1184404 · DOI · Paper page
  10. Grimson, 2007, MicroRNA targeting specificity in mammals: determinants beyond seed pairing, Mol Cell, 27, 91, 10.1016/j.molcel.2007.06.017 · DOI · Paper page
  11. Tam, 1997, bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA, Mol Cell Biol, 17, 1490, 10.1128/MCB.17.3.1490 · DOI · Paper page
  12. Tam, 2001, Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA, Gene, 274, 157, 10.1016/S0378-1119(01)00612-6 · DOI · Paper page
  13. Zheng, 2010, MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts, Biochem Biophys Res Commun, 400, 483, 10.1016/j.bbrc.2010.08.067 · DOI
  14. Masaki, 2007, Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis, Biochem Biophys Res Commun, 364, 509, 10.1016/j.bbrc.2007.10.077 · DOI · Paper page
  15. Georgantas, 2007, CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control, Proc Natl Acad Sci U S A, 104, 2750, 10.1073/pnas.0610983104 · DOI · Paper page
  16. Griffiths-Jones, 2004, The microRNA registry, Nucleic Acids Res, 32, D109, 10.1093/nar/gkh023 · DOI · Paper page
  17. Ohanian, 2013, A heterozygous variant in the human cardiac miR-133 gene, MIR133A2, alters miRNA duplex processing and strand abundance, BMC Genet, 14, 18, 10.1186/1471-2156-14-18 · DOI · Paper page
  18. Lee, 2013, Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing, Nucleic Acids Res, 41, 6568, 10.1093/nar/gkt361 · DOI · Paper page
  19. Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat Rev Genet, 9, 102, 10.1038/nrg2290 · DOI
  20. Zhou, 2010, miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells, Blood, 116, 5885, 10.1182/blood-2010-04-280156 · DOI · Paper page
  21. Tarassishin, 2011, Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155, Glia, 59, 1911, 10.1002/glia.21233 · DOI
  22. Kurowska-Stolarska, 2017, The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis, J Allergy Clin Immunol, 139, 1946, 10.1016/j.jaci.2016.09.021 · DOI
  23. Bruning, 2011, MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia, Mol Cell Biol, 31, 4087, 10.1128/MCB.01276-10 · DOI · Paper page
  24. Quinn, 2014, The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10, J Biol Chem, 289, 4316, 10.1074/jbc.M113.522730 · DOI · Paper page
  25. Pottier, 2009, Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions, PLoS One, 4, e6718, 10.1371/journal.pone.0006718 · DOI · Paper page
  26. Kong, 2008, MicroRNA-155 is regulated by the transforming growth factor beta/smad pathway and contributes to epithelial cell plasticity by targeting RhoA, Mol Cell Biol, 28, 6773, 10.1128/MCB.00941-08 · DOI · Paper page
  27. Valeri, 2010, Modulation of mismatch repair and genomic stability by miR-155, Proc Natl Acad Sci U S A, 107, 6982, 10.1073/pnas.1002472107 · DOI · Paper page
  28. Rajasagi, 2017, Frontline science: aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology, J Leukoc Biol, 102, 1159, 10.1189/jlb.3HI1216-511RR · DOI
  29. Zheng, 2012, Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism, Free Radic Biol Med, 52, 1307, 10.1016/j.freeradbiomed.2012.01.031 · DOI
  30. Chinenov, 2014, Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages, BMC Genomics, 15, 656, 10.1186/1471-2164-15-656 · DOI
  31. Bhattacharyya, 2013, Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNA-destabilizing proteins, KSRP and TTP, Biochem Biophys Res Commun, 433, 484, 10.1016/j.bbrc.2013.03.025 · DOI
  32. Boldin, 2011, miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice, J Exp Med, 208, 1189, 10.1084/jem.20101823 · DOI · Paper page
  33. Elton, 2013, Regulation of the MIR155 host gene in physiological and pathological processes, Gene, 532, 1, 10.1016/j.gene.2012.12.009 · DOI · Paper page
  34. Murray, 2014, Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, 41, 14, 10.1016/j.immuni.2014.06.008 · DOI · Paper page
  35. Misharin, 2014, Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice, Cell Rep, 9, 591, 10.1016/j.celrep.2014.09.032 · DOI · Paper page
  36. Self-Fordham, 2017, MicroRNA: dynamic regulators of macrophage polarization and plasticity, Front Immunol, 8, 1062, 10.3389/fimmu.2017.01062 · DOI
  37. An, 2005, Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism, Blood, 105, 4685, 10.1182/blood-2005-01-0191 · DOI · Paper page
  38. Wang, 2010, Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1, J Immunol, 185, 6226, 10.4049/jimmunol.1000491 · DOI · Paper page
  39. Nazari-Jahantigh, 2012, MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages, J Clin Invest, 122, 4190, 10.1172/JCI61716 · DOI · Paper page
  40. Kurowska-Stolarska, 2011, MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis, Proc Natl Acad Sci U S A, 108, 11193, 10.1073/pnas.1019536108 · DOI · Paper page
  41. Jing, 2015, CRISPR/CAS9-mediated genome editing of miRNA-155 inhibits proinflammatory cytokine production by RAW264.7 cells, Biomed Res Int, 2015, 326042, 10.1155/2015/326042 · DOI
  42. He, 2009, MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta, Cell Mol Immunol, 6, 343, 10.1038/cmi.2009.45 · DOI · Paper page
  43. Kim, 2017, The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages, Sci Rep, 7, 7591, 10.1038/s41598-017-07381-8 · DOI · Paper page
  44. Martinez-Nunez, 2011, The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1), J Biol Chem, 286, 1786, 10.1074/jbc.M110.169367 · DOI · Paper page
  45. Wahl, 1993, Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta, J Exp Med, 177, 225, 10.1084/jem.177.1.225 · DOI
  46. Louafi, 2010, MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}, J Biol Chem, 285, 41328, 10.1074/jbc.M110.146852 · DOI · Paper page
  47. Bluml, 2011, Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice, Arthritis Rheum, 63, 1281, 10.1002/art.30281 · DOI · Paper page
  48. Elmesmari, 2016, MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in rheumatoid arthritis, Rheumatology (Oxford), 55, 2056, 10.1093/rheumatology/kew272 · DOI
  49. Stanczyk, 2008, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, 58, 1001, 10.1002/art.23386 · DOI · Paper page
  50. Tian, 2014, Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis, Cardiovasc Res, 103, 100, 10.1093/cvr/cvu070 · DOI
  51. Herenius, 2011, Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab, Ann Rheum Dis, 70, 1160, 10.1136/ard.2010.141549 · DOI
  52. Asquith, 2015, Targeting cell migration in rheumatoid arthritis, Curr Opin Rheumatol, 27, 204, 10.1097/BOR.0000000000000150 · DOI
  53. Yoon, 2014, Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA), PLoS One, 9, e109775, 10.1371/journal.pone.0109775 · DOI
  54. Walter, 2013, Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells, Arthritis Rheum, 65, 627, 10.1002/art.37832 · DOI
  55. Evans, 2009, In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses, Proc Natl Acad Sci U S A, 106, 6232, 10.1073/pnas.0808144106 · DOI · Paper page
  56. Firestein, 1987, Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. i. a cytofluorographic study of monocyte differentiation antigens and class ii antigens and their regulation by γgm-interferon, Arthritis Rheum, 30, 857, 10.1002/art.1780300803 · doi:10.1002/art.1780300803
  57. Highton, 2008, Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis, Clin Exp Immunol, 102, 541, 10.1111/j.1365-2249.1995.tb03850.x · doi:10.1111/j.1365-2249.1995.tb03850.x
  58. De Rycke, 2005, Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis, J Pathol, 206, 17, 10.1002/path.1758 · DOI
  59. Chu, 1991, Localization of tumor-necrosis-factor-alpha in synovial tissues and at the cartilage pannus junction in patients with rheumatoid-arthritis, Arthritis Rheum, 34, 1125, 10.1002/art.1780340908 · DOI · Paper page
  60. Danks, 2002, Synovial macrophage-osteoclast differentiation in inflammatory arthritis, Ann Rheum Dis, 61, 916, 10.1136/ard.61.10.916 · DOI
  61. Adamopoulos, 2006, Synovial fluid macrophages are capable of osteoclast formation and resorption, J Pathol, 208, 35, 10.1002/path.1891 · DOI
  62. Syed, 2015, miR155 expression is increased by inflammation and modulates the expression of CD11a in monocytes, FASEB J, 29, 634.6, 10.1096/fasebj.29.1_supplement.634.6 · DOI
  63. Perlman, 2001, Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1?-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis, Arthritis Rheum, 44, 21, 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8 · doi:10.1002/1529-0131(200101)44:1<21::aid-anr4>3.0.co;2-8
  64. Liu, 2006, Regulation of Mcl-1 expression in rheumatoid arthritis synovial macrophages, Arthritis Rheum, 54, 3174, 10.1002/art.22132 · DOI
  65. Meusch, 2009, Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes, Arthritis Rheum, 60, 2612, 10.1002/art.24778 · DOI
  66. Srivastava, 2010, Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis, Clin Immunol, 136, 257, 10.1016/j.clim.2010.04.003 · DOI
  67. Rajasekhar, 2017, MicroRNA-155 contributes to enhanced resistance to apoptosis in monocytes from patients with rheumatoid arthritis, J Autoimmun, 79, 53, 10.1016/j.jaut.2017.01.002 · DOI
  68. Wang, 2017, Macrophage-derived mir-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury, Mol Ther, 25, 192, 10.1016/j.ymthe.2016.09.001 · DOI · Paper page
  69. Steinman, 2007, Taking dendritic cells into medicine, Nature, 449, 419, 10.1038/nature06175 · DOI · Paper page
  70. Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 · DOI · Paper page
  71. Zhou, 2017, The development and function of dendritic cell populations and their regulation by miRNAs, Protein Cell, 8, 501, 10.1007/s13238-017-0398-2 · DOI
  72. Reis e Sousa, 2006, Dendritic cells in a mature age, Nat Rev Immunol, 6, 476, 10.1038/nri1845 · DOI · Paper page
  73. Kawai, 2006, TLR signaling, Cell Death Differ, 13, 816, 10.1038/sj.cdd.4401850 · DOI · Paper page
  74. Dunand-Sauthier, 2011, Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function, Blood, 117, 4490, 10.1182/blood-2010-09-308064 · DOI
  75. Ceppi, 2009, MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells, Proc Natl Acad Sci U S A, 106, 2735, 10.1073/pnas.0811073106 · DOI · Paper page
  76. Martinez-Nunez, 2009, MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN), J Biol Chem, 284, 16334, 10.1074/jbc.M109.011601 · DOI · Paper page
  77. Shen, 2008, Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation, J Immunol, 181, 1849, 10.4049/jimmunol.181.3.1849 · DOI · Paper page
  78. Dudziak, 2007, Differential antigen processing by dendritic cell subsets in vivo, Science, 315, 107, 10.1126/science.1136080 · DOI · Paper page
  79. Lind, 2015, miR-155 upregulation in dendritic cells is sufficient to break tolerance in vivo by negatively regulating SHIP1, J Immunol, 195, 4632, 10.4049/jimmunol.1302941 · DOI
  80. Lu, 2011, miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1, Blood, 117, 4293, 10.1182/blood-2010-12-322503 · DOI · Paper page
  81. Jongbloed, 2006, Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis, Arthritis Res Ther, 8, R15, 10.1186/ar1864 · DOI · Paper page
  82. Kurowska-Stolarska, 2017, MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis, Nat Commun, 8, 15877, 10.1038/ncomms15877 · DOI
  83. Moret, 2015, The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines, Arthritis Rheumatol, 67, 637, 10.1002/art.38982 · DOI
  84. Moret, 2013, Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity, Arthritis Res Ther, 15, R155, 10.1186/ar4338 · DOI
  85. Thai, 2007, Regulation of the germinal center response by microRNA-155, Science, 316, 604, 10.1126/science.1141229 · DOI · Paper page
  86. Musilova, 2015, MicroRNAs in B-cell lymphomas: how a complex biology gets more complex, Leukemia, 29, 1004, 10.1038/leu.2014.351 · DOI · Paper page
  87. Costinean, 2009, Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice, Blood, 114, 1374, 10.1182/blood-2009-05-220814 · DOI · Paper page
  88. Costinean, 2006, Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice, Proc Natl Acad Sci U S A, 103, 7024, 10.1073/pnas.0602266103 · DOI · Paper page
  89. Sandhu, 2012, miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the E mu-miR-155 transgenic mouse model, Proc Natl Acad Sci U S A, 109, 20047, 10.1073/pnas.1213764109 · DOI
  90. Jiang, 2014, MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-beta1/SMAD5 signaling module, Blood, 123, 86, 10.1182/blood-2013-07-515254 · DOI
  91. Babar, 2012, Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma, Proc Natl Acad Sci U S A, 109, E1695, 10.1073/pnas.1201516109 · DOI · Paper page
  92. Klein, 2008, Germinal centres: role in B-cell physiology and malignancy, Nat Rev Immunol, 8, 22, 10.1038/nri2217 · DOI · Paper page
  93. Cui, 2014, MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia, Blood, 124, 546, 10.1182/blood-2014-03-559690 · DOI · Paper page
  94. Vigorito, 2007, microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells, Immunity, 27, 847, 10.1016/j.immuni.2007.10.009 · DOI · Paper page
  95. Thai, 2013, Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse, Proc Natl Acad Sci U S A, 110, 20194, 10.1073/pnas.1317632110 · DOI
  96. Lu, 2014, The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation, J Exp Med, 211, 2183, 10.1084/jem.20140338 · DOI
  97. Liu, 2015, TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE, Eur J Immunol, 45, 1934, 10.1002/eji.201445286 · DOI
  98. van de Stadt, 2011, Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis, Arthritis Rheum, 63, 3226, 10.1002/art.30537 · DOI · Paper page
  99. Ferraccioli, 2012, Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis, PLoS One, 7, e40362, 10.1371/journal.pone.0040362 · DOI
  100. Fekete, 2007, Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses, J Autoimmun, 29, 154, 10.1016/j.jaut.2007.07.002 · DOI
  101. Souto-Carneiro, 2009, Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor, Arthritis Res Ther, 11, R84, 10.1186/ar2718 · DOI
  102. Fedele, 2014, Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis, BMC Immunol, 15, 28, 10.1186/s12865-014-0028-1 · doi:10.1186/s12865-014-0028-1
  103. Alivernini, 2016, MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis, Nat Commun, 7, 12970, 10.1038/ncomms12970 · DOI
  104. Mahmood, 2015, CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis, Arthritis Res Ther, 17, 61, 10.1186/s13075-015-0580-y · DOI
  105. Rodriguez-Bayona, 2010, Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients, Arthritis Res Ther, 12, R108, 10.1186/ar3042 · DOI
  106. Tangye, 2009, Memory B cells: effectors of long-lived immune responses, Eur J Immunol, 39, 2065, 10.1002/eji.200939531 · DOI · Paper page
  107. Orr, 2017, Synovial immunophenotype and anti-citrullinated peptide antibodies in rheumatoid arthritis patients: relationship to treatment response and radiologic prognosis, Arthritis Rheumatol, 69, 2114, 10.1002/art.40218 · DOI
  108. Pitzalis, 2013, New learnings on the pathophysiology of RA from synovial biopsies, Curr Opin Rheumatol, 25, 334, 10.1097/BOR.0b013e32835fd8eb · DOI · Paper page
  109. Reiner, 2007, Development in motion: helper T cells at work, Cell, 129, 33, 10.1016/j.cell.2007.03.019 · DOI · Paper page
  110. Cobb, 2005, T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer, J Exp Med, 201, 1367, 10.1084/jem.20050572 · DOI · Paper page
  111. Muljo, 2005, Aberrant T cell differentiation in the absence of Dicer, J Exp Med, 202, 261, 10.1084/jem.20050678 · DOI · Paper page
  112. Banerjee, 2010, Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells, Eur J Immunol, 40, 225, 10.1002/eji.200939381 · DOI · Paper page
  113. Eis, 2005, Accumulation of miR-155 and BIC RNA in human B cell lymphomas, Proc Natl Acad Sci U S A, 102, 3627, 10.1073/pnas.0500613102 · DOI · Paper page
  114. Haasch, 2002, T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC, Cell Immunol, 217, 78, 10.1016/S0008-8749(02)00506-3 · DOI · Paper page
  115. van den Berg, 2003, High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma, Genes Chromosomes Cancer, 37, 20, 10.1002/gcc.10186 · DOI · Paper page
  116. Malmhall, 2014, MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung, J Allergy Clin Immunol, 133, 1429, 10.1016/j.jaci.2013.11.008 · DOI · Paper page
  117. Okoye, 2014, Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in mediating allergy and antihelminth immunity, Proc Natl Acad Sci U S A, 111, E3081, 10.1073/pnas.1406322111 · DOI
  118. Escobar, 2014, miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression, Immunity, 40, 865, 10.1016/j.immuni.2014.03.014 · DOI · Paper page
  119. Hu, 2013, MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression, J Immunol, 190, 5972, 10.4049/jimmunol.1300351 · DOI
  120. Hu, 2014, miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation, Immunity, 41, 605, 10.1016/j.immuni.2014.09.015 · DOI · Paper page
  121. Kohlhaas, 2009, Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells, J Immunol, 182, 2578, 10.4049/jimmunol.0803162 · DOI · Paper page
  122. Lu, 2009, Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein, Immunity, 30, 80, 10.1016/j.immuni.2008.11.010 · DOI · Paper page
  123. Asirvatham, 2008, MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components, Mol Immunol, 45, 1995, 10.1016/j.molimm.2007.10.035 · DOI · Paper page
  124. Sonkoly, 2010, MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4, J Allergy ClinImmunol, 126, 581, 10.1016/j.jaci.2010.05.045 · DOI · Paper page
  125. Zhang, 2010, Dicer controls CD8+ T-cell activation, migration, and survival, Proc Natl Acad Sci U S A, 107, 21629, 10.1073/pnas.1016299107 · DOI
  126. Gracias, 2013, The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling, Nat Immunol, 14, 593, 10.1038/ni.2576 · DOI · Paper page
  127. Smigielska-Czepiel, 2014, Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs, Genes Immun, 15, 115, 10.1038/gene.2013.69 · DOI
  128. Dejaco, 2010, Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica, Rheumatol Int, 30, 297, 10.1007/s00296-009-0949-9 · DOI
  129. Mottonen, 2005, CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis, Clin Exp Immunol, 140, 360, 10.1111/j.1365-2249.2005.02754.x · DOI · Paper page
  130. Raghavan, 2009, FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment, Ann Rheum Dis, 68, 1908, 10.1136/ard.2008.100768 · DOI
  131. van Amelsfort, 2004, CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid, Arthritis Rheum, 50, 2775, 10.1002/art.20499 · DOI · Paper page
  132. Valencia, 2006, TNF downmodulates the function of human CD4+CD25hi T-regulatory cells, Blood, 108, 253, 10.1182/blood-2005-11-4567 · DOI · Paper page
  133. Wehrens, 2013, T cells out of control – impaired immune regulation in the inflamed joint, Nat Rev Rheumatol, 9, 34, 10.1038/nrrheum.2012.149 · DOI
  134. Zhou, 2015, Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis, Ann Rheum Dis, 74, 1265, 10.1136/annrheumdis-2013-204377 · DOI · Paper page
  135. Garcia-Rodriguez, 2017, Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity, J Eur Acad Dermatol Venereol, 31, 312, 10.1111/jdv.13861 · DOI
  136. Jopling, 2005, Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA, Science, 309, 1577, 10.1126/science.1113329 · DOI · Paper page
  137. Misso, 2014, Mir-34: a new weapon against cancer?, Mol Ther Nucleic Acids, 3, e194, 10.1038/mtna.2014.47 · DOI · Paper page
  138. Millar, 2015, MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease, Nat Commun, 6, 6774, 10.1038/ncomms7774 · DOI · Paper page
  139. Morton, 2015, Neutralisation of miR-155 ameliorates collagen-induced arthritis, Ann Rheum Dis, 74, 84, 10.1136/annrheumdis-2015-207259.194 · doi:10.1136/annrheumdis-2015-207259.194
  140. Miller, 2013, MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice, PLoS One, 8, e72324, 10.1371/journal.pone.0072324 · DOI
  141. Cheng, 2015, MicroRNA silencing for cancer therapy targeted to the tumour microenvironment, Nature, 518, 107, 10.1038/nature13905 · DOI · Paper page
  142. Ng, 2010, Synovial tissue hypoxia and inflammation in vivo, Ann Rheum Dis, 69, 1389, 10.1136/ard.2009.119776 · DOI · Paper page
  143. Cross, 2017, AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis, Br J Pharmacol, 174, 3045, 10.1111/bph.13934 · DOI

Cited by

See all 228

Metadata

Authors
Alivernini, S., Gremese, E., McSharry, C., Tolusso, B., Ferraccioli, G., McInnes, I. B., & Kurowska-Stolarska, M.
Venue
Frontiers in Immunology
Published
2018-01-05
Volume
8
Pages
1932-1932
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2782197585
Cited by
228
References
22
FWCI
20.18
Type
journal article
Language
en
Open access
gold
Funders
Arthritis Research UK (RACE20298)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis. https://app.cochat.ai/papers/10.3389/fimmu.2017.01932
The paper
Alivernini, S., Gremese, E., McSharry, C., Tolusso, B., Ferraccioli, G., McInnes, I. B., & Kurowska-Stolarska, M. (2018). MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.01932

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.